Charlotta Andersson - ProstaLund Sales Finland
| PLUN Stock | SEK 9.00 2.00 28.57% |
Insider
Charlotta Andersson is Sales Finland of ProstaLund AB
| Phone | 46 46 12 09 08 |
| Web | https://prostalund.se |
ProstaLund Management Efficiency
The company has return on total asset (ROA) of (0.1309) % which means that it has lost $0.1309 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2484) %, meaning that it generated substantial loss on money invested by shareholders. ProstaLund's management efficiency ratios could be used to measure how well ProstaLund manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Fredrik Zetterberg | Episurf Medical AB | 48 | |
| Thomas Lundstrm | Acarix AS | 49 | |
| Christian Lindholm | Acarix AS | 59 | |
| Katarina Flodstrm | Episurf Medical AB | 48 | |
| Helen Round | Acarix AS | 59 | |
| Beata Lihammar | Episurf Medical AB | N/A | |
| Slavoljub Grujicic | Senzime AB | 53 | |
| Anders Krabbe | Acarix AS | 56 | |
| Johanna Tulkki | Senzime AB | 53 | |
| Anders Selin | Senzime AB | 61 | |
| Tobias Fritz | Acarix AS | 44 | |
| Michael Nsstrm | Episurf Medical AB | 34 | |
| Veronica Wallin | Episurf Medical AB | 37 | |
| Stephen Caswell | Episurf Medical AB | 42 | |
| Patrick Jamnik | Episurf Medical AB | 40 | |
| Pal Ryfors | Episurf Medical AB | 40 | |
| Linn Olsen | Scibase AB | 46 | |
| Michael Colrus | Scibase AB | 61 | |
| Marianne Norskov | Acarix AS | 45 | |
Management Performance
| Return On Equity | -0.25 | |||
| Return On Asset | -0.13 |
ProstaLund AB Leadership Team
Elected by the shareholders, the ProstaLund's board of directors comprises two types of representatives: ProstaLund inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ProstaLund. The board's role is to monitor ProstaLund's management team and ensure that shareholders' interests are well served. ProstaLund's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ProstaLund's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Erika Carlsson, Chief Officer | ||
| Charlotta Andersson, Sales Finland | ||
| Goran Dybner, Marketing Director | ||
| Leo Gurvich, Chief Marked | ||
| Johan Wennerholm, Chief Officer |
ProstaLund Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ProstaLund a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.61) % | |||
| Operating Margin | (0.59) % | |||
| Current Valuation | 215.81 M | |||
| Shares Outstanding | 57.19 M | |||
| Shares Owned By Insiders | 50.77 % | |||
| Shares Owned By Institutions | 1.93 % | |||
| Price To Book | 5.09 X | |||
| Price To Sales | 13.54 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ProstaLund Stock Analysis
When running ProstaLund's price analysis, check to measure ProstaLund's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProstaLund is operating at the current time. Most of ProstaLund's value examination focuses on studying past and present price action to predict the probability of ProstaLund's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProstaLund's price. Additionally, you may evaluate how the addition of ProstaLund to your portfolios can decrease your overall portfolio volatility.